Article
In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA.
Molecular therapy : the journal of the American Society of Gene Therapy - 1 Nov 2003
Yoshinouchi Mitsuo, Yamada Taketo, Kizaki Masahiro, Fen Jin, Koseki Takeyoshi, Ikeda Yasuo, Nishihara Tatsuji, Yamato Kenji
Abstract excerpt
Human papillomavirus type 16 (HPV16), a causative agent of cervical cancers, encodes the E6 and E7 oncogenes, whose simultaneous expression is pivotal for malignant transformation and maintenance of malignant phenotypes. In the hope of developing a gene-specific therapy for HPV-related cancer, we examined the effects of E6 short-interfering RNA (siRNA) on the expression of these oncogenes and on the cell growth...
Topics
- Animals
- COS Cells
- Cell Line
- Cell Line, Tumor
- Cell Nucleus
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclins
- Female
- Humans
- In Vitro Techniques
